Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation
Review
. 2022 Sep;12(9):3529-3547.
doi: 10.1016/j.apsb.2022.05.001. Epub 2022 May 11.

Therapeutic potential of traditional Chinese medicine for the treatment of NAFLD: A promising drug Potentilla discolor Bunge

Affiliations
Review

Therapeutic potential of traditional Chinese medicine for the treatment of NAFLD: A promising drug Potentilla discolor Bunge

Longshan Ji et al. Acta Pharm Sin B. 2022 Sep.

Abstract

Nonalcoholic fatty liver disease (NAFLD) is characterized by excessive accumulation of hepatic lipids and metabolic stress-induced liver injury. There are currently no approved effective pharmacological treatments for NAFLD. Traditional Chinese medicine (TCM) has been used for centuries to treat patients with chronic liver diseases without clear disease types and mechanisms. More recently, TCM has been shown to have unique advantages in the treatment of NAFLD. We performed a systematic review of the medical literature published over the last two decades and found that many TCM formulas have been reported to be beneficial for the treatment of metabolic dysfunctions, including Potentilla discolor Bunge (PDB). PDB has a variety of active compounds, including flavonoids, terpenoids, organic acids, steroids and tannins. Many compounds have been shown to exhibit a series of beneficial effects for the treatment of NAFLD, including anti-oxidative and anti-inflammatory functions, improvement of lipid metabolism and reversal of insulin resistance. In this review, we summarize potential therapeutic effects of TCM formulas for the treatment of NAFLD, focusing on the medicinal properties of natural active compounds from PDB and their underlying mechanisms. We point out that PDB can be classified as a novel candidate for the treatment and prevention of NAFLD.

Keywords: Acupuncture; Anti-inflammatory; Anti-oxidative; Endoplasmic reticulum stress; Insulin resistance; Intestinal microflora; Lipid metabolism; Natural active compounds; Nonalcoholic fatty liver disease (NAFLD); Potentilla discolor Bunge (PDB); Traditional Chinese medicine.

PubMed Disclaimer

Conflict of interest statement

The authors declare no conflicts of interest.

Figures

Image 1
Graphical abstract
Figure 1
Figure 1
Pathogenesis of NAFLD: inter-tissue crosstalk between the liver, the intestine, and adipose tissue. (i) Gut barrier dysfunction and disruption of barrier integrity cause translocation of bacteria or bacterial products into the blood circulation, resulting in liver inflammation and the progression towards NASH. (ii) The intricate crosstalk between adipose tissue and the liver contributes to the progression of NAFLD. (iii) KCs produce TNF, TRAIL and FAS ligands through phagocytosis of apoptotic bodies, which subsequently promotes hepatocyte apoptosis, causing hepatitis and fibrosis. EVs released from hepatocytes contribute to hepatic recruitment of monocyte-derived macrophages. (iv) The up-regulation of hepatic chemokines CXCL1 and IL-8 and resulting infiltration of neutrophils are hallmarks of NASH.
Figure 2
Figure 2
Mechanisms of the classical TCM formulas for the treatment of NAFLD. The classical formulas of TCM exhibit a series of beneficial effects for the treatment of NAFLD, including improvement of lipid metabolism and IR, regulation of cytokines, anti-inflammatory responses, inhibition of apoptosis, and regulation of intestinal microflora.
Figure 3
Figure 3
Structure backbones of the main components of PDB.
Figure 4
Figure 4
Functions of the main natural active compounds of PDB. Flavonoids improve lipid metabolism and IR, reduce oxidative stress and ER stress, and regulate the intestinal microflora. Organic acids regulate the intestinal microflora. The terpenoids improve lipid metabolism and inhibit endoplasmic reticulum stress. The steroids improve IR.

References

    1. Eslam M., Sanyal A.J., George J. MAFLD: a consensus-driven proposed nomenclature for metabolic associated aatty liver disease. Gastroenterology. 2020;158:1999–2014.e1. - PubMed
    1. Younossi Z., Tacke F., Arrese M., Chander Sharma B., Mostafa I., Bugianesi E., et al. Global perspectives on nonalcoholic fatty liver disease and nonalcoholic steatohepatitis. Hepatology. 2019;69:2672–2682. - PubMed
    1. Noureddin M., Sanyal A.J. Pathogenesis of NASH: the impact of multiple pathways. Curr Hepat Rep. 2018;17:350–360. - PMC - PubMed
    1. Dufour J.F., Caussy C., Loomba R. Combination therapy for non-alcoholic steatohepatitis: rationale, opportunities and challenges. Gut. 2020;69:1877–1884. - PMC - PubMed
    1. Kefala G., Tziomalos K. Apoptosis signal-regulating kinase-1 as a therapeutic target in nonalcoholic fatty liver disease. Expet Rev Gastroenterol Hepatol. 2019;13:189–191. - PubMed

LinkOut - more resources